Showing 201-210 of 355 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Investigation of novel local immunomodulating strategies to enhance islet transplantation for T1D | The Methodist Hospital Research Institute | Alessandro Grattoni | Cures | 01-July-2022 to 30-June-2027 | $962.995,99 |
| Tolerance inducing NanoLymph for in vivo generation of islet autoantigen-specific regulatory T cells | The Methodist Hospital Research Institute | Ying Xuan Chua | Cures | 01-April-2025 to 31-March-2027 | $200.000,00 |
| Building Organotypic Vascularized Pancreatic Islets with Real-Time 4D Tracking of Engraftment and Vascular Maturation | The Regents of the University of California, Los Angeles | Chen Yuan Kam | Cures | 01-April-2026 to 31-March-2027 | $200.000,00 |
| Antigen-specific immunotherapies based on ignored ß-cell antigen determinants. | The Regents of the University of California, Los Angeles | Daniel Kaufman | Cures | 01-October-2024 to 30-September-2027 | $573.101,00 |
| Multiplex in vivo imaging of the dynamics of immune-mediated rejection of allogenic islet grafts | The Regents of the University of California, Los Angeles | Oluwatayo Ikotun | Cures | 01-February-2024 to 31-January-2027 | $749.996,25 |
| Targeting Complement-Driven Antigen Presentation in Tertiary Lymphoid Structures to Prevent Type 1 Diabetes | The Regents of the University of California, San Francisco | Anil Bhushan | Cures | 01-September-2026 to 31-August-2028 | $498.142,00 |
| Local delivery of immunomodulators to enable systemic immunosuppression-free efficient islet transplantation | The Regents of the University of California, San Francisco | Bhushan Kharbikar | Cures | 01-March-2024 to 28-February-2027 | $215.604,64 |
| Reducing Diabetes Distress in Adults with Type 1 Diabetes: A pragmatic trial in routine diabetes care. | The Regents of the University of California, San Francisco | Danielle Hessler | Improving Lives | 01-August-2023 to 14-September-2027 | $1.743.010,00 |
| Sparing ER stressed human beta cells with novel kinase inhibitors of the unfolded protein response (UPR) | The Regents of the University of California, San Francisco | Feroz Papa | Cures | 01-August-2023 to 31-July-2027 | $960.000,00 |
| Creation of a single-cell derived shared autoimmune framework for the study of SLE, T1D, and MS | The Regents of the University of California, San Francisco | Gabriela Fragiadakis | Cures | 01-September-2026 to 31-August-2027 | $150.000,00 |